|
SPRED2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.319880E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.35699999517891E-08 |
| Normal-vs-Stage2 |
5.997800E-01 |
| Normal-vs-Stage3 |
8.664800E-01 |
| Normal-vs-Stage4 |
3.283400E-01 |
| Stage1-vs-Stage2 |
5.980900E-03 |
| Stage1-vs-Stage3 |
1.13769999998681E-06 |
| Stage1-vs-Stage4 |
1.36520000004747E-06 |
| Stage2-vs-Stage3 |
6.785200E-01 |
| Stage2-vs-Stage4 |
2.416200E-01 |
| Stage3-vs-Stage4 |
2.942000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.462610E-03 |
| Normal-vs-AfricanAmerican |
2.319600E-01 |
| Normal-vs-Asian |
3.503600E-01 |
| Caucasian-vs-AfricanAmerican |
7.325200E-01 |
| Caucasian-vs-Asian |
6.639800E-01 |
| AfricanAmerican-vs-Asian |
6.348400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.302000E-02 |
| Normal-vs-Female |
2.06799999999951E-05 |
| Male-vs-Female |
1.977420E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.260950E-01 |
| Normal-vs-Age(41-60Yrs) |
1.444520E-04 |
| Normal-vs-Age(61-80Yrs) |
6.955800E-02 |
| Normal-vs-Age(81-100Yrs) |
6.435000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.548600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.069000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.366970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.426400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.590400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.086200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.124280E-03 |
| Normal-vs-Grade 2 |
1.27939999705617E-08 |
| Normal-vs-Grade 3 |
8.318600E-01 |
| Normal-vs-Grade 4 |
8.233600E-02 |
| Grade 1-vs-Grade 2 |
5.381700E-03 |
| Grade 1-vs-Grade 3 |
1.242130E-03 |
| Grade 1-vs-Grade 4 |
3.79240000514258E-08 |
| Grade 2-vs-Grade 3 |
1.86149999858998E-08 |
| Grade 2-vs-Grade 4 |
4.26129997954661E-09 |
| Grade 3-vs-Grade 4 |
5.529900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.76010325706011E-11 |
| Normal-vs-ccB subtype |
9.541400E-01 |
| ccA subtype-vs-ccB subtype |
3.74769992816937E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.845700E-02 |
| Normal-vs-N1 |
2.301200E-01 |
| N0-vs-N1 |
6.623900E-02 |
|
|
